DSpace

DSpace at RU >

Browsing by Faculty / Department Clinical Pharmacy

Sort by: In order: Results/Page Authors/Record:
Showing results 21 to 40 of 428
Full TextIssue DateTitleAuthor(s)
2012Antibiotic use and resistance in long term care facilitiesvan Buul, L.W.; van der Steen, J.T.; Veenhuizen, R.B.; Achterberg, W.P.; Schellevis, F.G., et al
2010Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.Tostmann, A.; Boogaard, J. van den; Semvua, H.; Kisonga, R.; Kibiki, G.S., et al
2008Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.Tostmann, A.; Boeree, M.J.; Aarnoutse, R.E.; Lange, W.C.M. de; Ven, A.J.A.M. van der, et al
2011De apotheker draait doorBurger, David
2008Apotheker moet extra alert zijn. Bij thuisgebruik van oncolytica.Burger, D.M.; Grootscholten, M.I.; Koopman, M.; Bokhoven, M.M. van; Herpen, C.M.L. van
2012Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.Verwimp-Hoeks, M.P.; Herpen, C.M.L. van; Burger, D.M.
2007Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study.Munoz-Moreno, J.A.; Fumaz, C.R.; Ferrer, M.J.; Tuldra, A.; Rovira, T., et al
2010Assessment of antibacterial sale by using the Anatomic Therapeutic Chemical classification and defined daily dose methodology in Moshi Municipality, Northern Tanzania.Boogaard, J. van den; Semvua, H.H.; Boeree, M.J.; Aarnoutse, R.E.; Kibiki, G.S.
2006Assessment of drug-drug interactions between tenofovir disoproxil fumarate and the nonnucleoside reverse transcriptase inhibitors nevirapine and efavirenz in HIV-infected patientsDroste, J.A.H.; Kearney, B.P.; Hekster, Y.A.; Burger, D.M.
2005Assessment of the value of lamotrigine in daily practiceKnoester, P.D.
2012Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.Heil, S.G.; Ende, M.E. van der; Schenk, P.W.; Heiden, I. van der; Lindemans, J., et al
2007Atazanavir in plasma-exchange treatment.Attema-de Jonge, M.E.; Burger, D.M.; Franssen, E.J.; Brinkman, K.
2005Audits of antibiotic prescribing.Natsch, S.S.
2007Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.Schouten, J.A.; Hulscher, M.E.J.L.; Natsch, S.S.; Kullberg, B.J.; Meer, J.W.M. van der, et al
2008Beïnvloeding van behandelrichtlijnen door de farmaceutische industrieKramers, C.; Wuis, E.W.; Schouwenberg, B.J.J.W.
2011The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitusDekker, D.; Dorresteijn, M.J.; Pijnenburg, M.; Heemskerk, S.; Rasing-Hoogveld, A., et al
2004Bioavailability of rifampicin in Indonesian subjects: a comparison of different local drug manufacturers.Crevel, R. van; Nelwan, R.H.; Borst, F.; Sahiratmadja, E.; Cox, J., et al
2006Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).Boyd, M.A.; Srasuebkul, P.; Khongphattanayothin, M.; Ruxrungtham, K.; Hassink, E.A.M., et al
2006Brief report : enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy womenL'homme, R.F.A.; Dijkema, T.; Ven, A.J.A.M. van der; Burger, D.M.
2007Caffeine and muscle cramps: a stimulating connection.Molema, M.; Dekker, M.C.J.; Voermans, N.C.; Engelen, B.G.M. van; Aarnoutse, R.E.
Showing results 21 to 40 of 428

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback